Cns Pharmaceuticals Inc (NASDAQ:CNSP) has a beta value of 1.03 and has seen 180.94 million shares traded in the recent trading session. The company, currently valued at $7.85M, closed the recent trade at $0.13 per share which meant it gained $0.01 on the day or 5.53% during that session. The CNSP stock price is -46823.08% off its 52-week high price of $61.00 and 23.08% above the 52-week low of $0.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.46 million shares traded. The 3-month trading volume is 17.56 million shares.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Sporting 5.53% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CNSP stock price touched $0.13 or saw a rise of 20.0%. Year-to-date, Cns Pharmaceuticals Inc shares have moved 7.81%, while the 5-day performance has seen it change 14.97%. Over the past 30 days, the shares of Cns Pharmaceuticals Inc (NASDAQ:CNSP) have changed 19.52%. Short interest in the company has seen 1.14 million shares shorted with days to cover at 0.04.
Wall Street analysts have a consensus price target for the stock at $0.5, which means that the shares’ value could jump 74.0% from the levels at last check today. The projected low price target is $0.5 while the price target rests at a high of $0.5. In that case, then, we find that the latest price level in today’s session is -284.62% off the targeted high while a plunge would see the stock gain -284.62% from the levels at last check today.
CNSP Dividends
Cns Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders own 1.04% of the company shares, while shares held by institutions stand at 0.79% with a share float percentage of 0.80%. Investors are also buoyed by the number of investors in a company, with Cns Pharmaceuticals Inc having a total of 12.0 institutions that hold shares in the company.
